Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details)

v3.22.1
NON CONTROLLING INTEREST (Details) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Net loss attributable to the non-controlling interest $ (551) $ (776)
BioCorRx Pharmaceuticals, Inc [Member]    
Net loss $ (2,276) $ (3,207)
Average Non-controlling interest percentage of profit/losses 24.20% 24.20%
Net loss attributable to the non-controlling interest $ (551) $ (776)